Andere talen K2X Technology & Life Science, Inc.

Aandelen

KBPH

US5015722003

Vertraagde tijd OTC Markets Andere beurzen 21:30:56 22-08-2022			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
1 ^USD	-45,65%		-.--%	-.--%

2022	Kyto Technology and Life Science, Inc. maakt winst bekend over het derde kwartaal en de negen maanden eindigend op 31 december 2021	CI
2021	Kyto Technology and Life Science, Inc. Rapporteert Winstresultaten voor het Tweede Kwartaal en de Zes Maanden Geëindigd op 30 September, 2021	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

FluidAI Medical announced that it has received CAD 15 million in funding from a group of investors	10-10-23
Infinidome Ltd. announced that it has received $9 million in funding from Hanwha Aerospace Co., Ltd., Next Gear Ventures, Honeywell Ventures, VentureIsrael, Kyto Technology and Life Science, Inc., Aston Capital Management and another investor	24-04-23
Mrinq Technologies LLP announced that it has received $2.5 million in funding from a group of investors	10-11-22
KYTO TECHNOLOGY & LIFE SCIENCE, INC. : Other Events, Financial Statements and Exhibits (form 8-K)	09-05-22
Kyto Technology & Life Science Inc. Announces the Termination of Tender Offer	07-05-22
Kyto Technology & Life Science Inc. Announces the Termination of Tender Offer	07-05-22
KYTO TECHNOLOGY & LIFE SCIENCE, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITIONS AND RESULTS OF OPERATIONS (form 10-Q)	22-02-22
Kyto Technology and Life Science, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	22-02-22
KYTO TECHNOLOGY & LIFE SCIENCE, INC. : Unregistered Sale of Equity Securities (form 8-K)	09-02-22
Kyto Technology and Life Science, Inc. announced that it has received $2.620875 million in funding	04-02-22
Rhaeos, Inc. announced that it has received $2.2 million in funding from a group of investors	23-12-21
KYTO TECHNOLOGY & LIFE SCIENCE, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITIONS AND RESULTS OF OPERATIONS (form 10-Q)	18-11-21
Kyto Technology and Life Science, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021	18-11-21
KYTO TECHNOLOGY & LIFE SCIENCE, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	10-11-21
KYTO TECHNOLOGY & LIFE SCIENCE, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	12-10-21
Kyto Technology and Life Science : & LIFE SCIENCE, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITIONS AND RESULTS OF OPERATIONS (form 10-Q/A)	06-10-21
Kyto Technology and Life Science : & LIFE SCIENCE, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITIONS AND RESULTS OF OPERATIONS (form 10-Q)	01-10-21
Kyto Technology and Life Science, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2021	01-10-21
KYTO TECHNOLOGY & LIFE SCIENCE, INC. : Unregistered Sale of Equity Securities (form 8-K)	08-09-21
Kyto Technology and Life Science, Inc. announced that it has received $0.21 million in funding	01-09-21

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen K2X Technology & Life Science, Inc.

Aandelen

KBPH

US5015722003

Andere talen

Filters